000042121 000__ 02007cam\a22002535i\4500
000042121 001__ 42121
000042121 003__ SzGeWIPO
000042121 005__ 20240708145901.0
000042121 008__ 200625s2016\\\\sz\\\\\\r\\\\\000\0\eng\d
000042121 040__ $$aSzGeWIPO$$beng$$erda
000042121 041__ $$aeng
000042121 1001_ $$aHolman, Christopher M.
000042121 24503 $$aThe Mayo Framework Is Bad for Your Health
000042121 264_1 $$a[Fairfax, Virginia] :$$bGeorge Mason University,$$c2016.
000042121 300__ $$a40 pages
000042121 336__ $$atext$$btxt$$2rdacontent
000042121 337__ $$aunmediated$$bn$$2rdamedia
000042121 338__ $$avolume$$bnc$$2rdacarrier
000042121 520__ $$aThis Article begins by providing a brief historical retrospective of the development of the patent eligibility doctrine, and then delves into the related questions of: (1) what are the Supreme Court’s policy objectives for the recent reinvigoration of the patent eligibility doctrine; and (2) has it achieved those objectives? The article then discusses three important out-standing questions regarding the application of the new test for patent eligibility: (1) what constitutes a natural phenomenon; (2) what constitutes an inventive step; and (3) what, if any, role does preemption play in the analysis? The article then provides four examples of recent lower court decisions that have applied the new test, often referred to as the Mayo Framework, in a literal manner. This application has resulted in the invalidation of claims directed towards processes that would have easily passed patent eligibility muster prior to the most recent wave of Supreme Court decisions. The Article concludes by suggesting that the Supreme Court should revisit the question of patent eligibility and re-articulate the standard in a manner better-suited to ensure the availability of meaningful patent protection for the next generation of innovation, particularly in the life sciences. If the Court fails to do so, Congress should seriously consider addressing the problem through an amendment of the statute.
000042121 525__ $$aPublished in : George Mason Law Review
000042121 605_0 $$aPatent eligibility
000042121 650__ $$aPatent
000042121 650_0 $$aMayo
000042121 650_0 $$aBiotechnology
000042121 650_0 $$aDiagnostics
000042121 85641 $$uhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=3592905$$yView this resource
000042121 904__ $$aJournal article
000042121 980__ $$aBIB